Our data revealed that SHCBP1 silencing inhibited tumor cell migration and invasion, which was accompanied with the reduced expression of mesenchymal markers N-cadherin and vimentin and the elevated expression of epithelial markers E-cadherin. The gene discussed is CDH1; the disease is neoplasm.